DE602004029465D1 - Externes Präparat zur Behandlung von Fusspilz - Google Patents

Externes Präparat zur Behandlung von Fusspilz

Info

Publication number
DE602004029465D1
DE602004029465D1 DE602004029465T DE602004029465T DE602004029465D1 DE 602004029465 D1 DE602004029465 D1 DE 602004029465D1 DE 602004029465 T DE602004029465 T DE 602004029465T DE 602004029465 T DE602004029465 T DE 602004029465T DE 602004029465 D1 DE602004029465 D1 DE 602004029465D1
Authority
DE
Germany
Prior art keywords
athlete
foot
treatment
external preparation
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004029465T
Other languages
English (en)
Inventor
Toshihiro Shirouzu
Youichi Kawamura
Hiroki Kawatsura
Mitsuhiko Tokunaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE602004029465D1 publication Critical patent/DE602004029465D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004029465T 2003-06-25 2004-06-25 Externes Präparat zur Behandlung von Fusspilz Expired - Lifetime DE602004029465D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003181264 2003-06-25
JP2003407136 2003-12-05
PCT/JP2004/008992 WO2005000287A1 (ja) 2003-06-25 2004-06-25 水虫治療用外用剤

Publications (1)

Publication Number Publication Date
DE602004029465D1 true DE602004029465D1 (de) 2010-11-18

Family

ID=33554443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029465T Expired - Lifetime DE602004029465D1 (de) 2003-06-25 2004-06-25 Externes Präparat zur Behandlung von Fusspilz

Country Status (5)

Country Link
US (3) US20070099932A1 (de)
EP (1) EP1637132B1 (de)
JP (3) JPWO2005000287A1 (de)
DE (1) DE602004029465D1 (de)
WO (1) WO2005000287A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004029465D1 (de) * 2003-06-25 2010-11-18 Hisamitsu Pharmaceutical Co Externes Präparat zur Behandlung von Fusspilz
JP2007091661A (ja) * 2005-09-29 2007-04-12 Nippon Nohyaku Co Ltd 外用抗真菌剤組成物
JP4974526B2 (ja) * 2005-12-29 2012-07-11 ロート製薬株式会社 カンジダ症の予防又は治療用組成物
RU2423128C2 (ru) 2006-03-08 2011-07-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
NZ571818A (en) * 2006-03-08 2011-10-28 Nihon Nohyaku Co Ltd External pharmaceutical composition comprising luliconazole and an alpha-hydroxycarboxylic acid such as lactic acid, glycolic acid or malic acid.
JP5025985B2 (ja) * 2006-04-27 2012-09-12 株式会社Ａｄｅｋａ 抗菌剤及びこれを含有する抗菌性組成物
WO2007131253A2 (de) 2006-05-12 2007-11-22 Pharmacon-Forschung Und Beratung Gmbh Verwendung von kombinationspräparaten, umfassend antimykotika
JP5033381B2 (ja) * 2006-09-14 2012-09-26 株式会社池田模範堂 外用医薬組成物
JP5872131B2 (ja) * 2006-11-29 2016-03-01 ロート製薬株式会社 抗真菌医薬組成物
EP2191826B1 (de) 2007-09-05 2017-03-08 Pola Pharma Inc. Pharmazeutische zusammensetzung
EP2191828B1 (de) * 2007-09-05 2016-08-10 Pola Pharma Inc. Antimykotische pharmazeutische zusammensetzung
US20100173965A1 (en) * 2007-09-05 2010-07-08 Pola Pharma Inc. Antifungal composition
JP5319950B2 (ja) * 2008-04-08 2013-10-16 帝國製薬株式会社 塩酸ブテナフィン含有水性貼付剤
WO2010117091A2 (en) * 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
JP5735750B2 (ja) * 2010-03-30 2015-06-17 小林製薬株式会社 抗真菌組成物
JP5460766B2 (ja) * 2012-03-15 2014-04-02 株式会社池田模範堂 外用医薬組成物
CN104133016B (zh) * 2014-07-25 2015-09-09 江苏云阳集团药业有限公司 一种盐酸奈康唑的高效液相色谱分析方法
JP7139206B2 (ja) * 2018-09-21 2022-09-20 小林製薬株式会社 医薬組成物
US11663124B2 (en) * 2020-02-25 2023-05-30 Micron Technology, Inc. Apparatuses and methods for interfacing on-memory pattern matching

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945084A (en) * 1987-07-08 1990-07-31 Norman Oksman Method and composition for topically treating anorectal or other dermal wounds
US4873265A (en) * 1988-07-14 1989-10-10 Thomes Pharmacal Co., Inc. Anti-infective methods and compositions
JPH0338522A (ja) 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
WO1994026309A1 (en) * 1993-05-19 1994-11-24 Hisamitsu Pharmaceutical Co., Inc. Solubilizing agent and external preparation containing the same
JPH07233088A (ja) 1993-12-27 1995-09-05 Takeda Chem Ind Ltd 局所外用剤
JP3629283B2 (ja) * 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3803695B2 (ja) * 1994-11-28 2006-08-02 サンスター株式会社 抗菌製剤
DE69632148T2 (de) * 1995-12-14 2005-03-17 Taisho Pharmaceutical Co., Ltd. Aerosolzubereitung
JP3793596B2 (ja) 1995-12-26 2006-07-05 大鵬薬品工業株式会社 抗真菌性外用組成物
JPH10265377A (ja) * 1997-03-24 1998-10-06 Pola Chem Ind Inc 抗真菌剤及びその製造方法
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
JP4201898B2 (ja) * 1998-10-21 2008-12-24 株式会社ロッテ 抗菌製剤
JP2001128801A (ja) 1999-11-02 2001-05-15 Nakatani Sangyo Kk マット
JP2004500404A (ja) * 2000-03-27 2004-01-08 カール　−　ツァイス　−　シュティフツング 生物活性ガラスを含む新規化粧品、ボディケア、洗浄剤および栄養サプリメント組成物および製造方法およびその使用
JP4666716B2 (ja) * 2000-05-26 2011-04-06 株式会社ダイゾー エアゾール製品
DE60111217T2 (de) * 2000-06-12 2006-04-27 Symrise Gmbh & Co. Kg Nichttoxische beschichtungszusammensetzung, verwendungsverfahren und gegen die anlagerung von biofouling-organismen behandelte gegenstände
JP2002284702A (ja) * 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
US20030194445A1 (en) * 2001-11-12 2003-10-16 Kuhner Carla H. Compositions and methods of use of peptides in combination with biocides and/or germicides
CN1368051A (zh) * 2002-02-10 2002-09-11 汤毅 一种治疗皮肤病的药物组合物
JP4963776B2 (ja) 2002-03-08 2012-06-27 第一三共ヘルスケア株式会社 抗真菌活性増強型組成物及び抗真菌活性増強方法
JP4081312B2 (ja) * 2002-06-28 2008-04-23 佐藤製薬株式会社 外用抗真菌剤
DE602004029465D1 (de) * 2003-06-25 2010-11-18 Hisamitsu Pharmaceutical Co Externes Präparat zur Behandlung von Fusspilz

Also Published As

Publication number Publication date
EP1637132A4 (de) 2008-01-09
US20110269794A1 (en) 2011-11-03
US8664224B2 (en) 2014-03-04
JP2008239626A (ja) 2008-10-09
JP4828563B2 (ja) 2011-11-30
JPWO2005000287A1 (ja) 2006-10-05
US20090099202A1 (en) 2009-04-16
US20070099932A1 (en) 2007-05-03
WO2005000287A1 (ja) 2005-01-06
JP2009007365A (ja) 2009-01-15
EP1637132A1 (de) 2006-03-22
EP1637132B1 (de) 2010-10-06

Similar Documents

Publication Publication Date Title
DE602004029465D1 (de) Externes Präparat zur Behandlung von Fusspilz
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE60230425D1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
DE602004022061D1 (de) Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE551100T1 (de) Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen
ATE417037T1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE518841T1 (de) Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
ATE413385T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten